CLX earnings analysis
What we found in CLX's 10-K: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
Clorox retains a strong branded portfolio, with more than 80% of sales from No. 1 or No. 2 category brands, and the GOJO acquisition broadens its health-and-hygiene and B2B positioning. However, fiscal 2026 showed weakening demand and earnings, including a 26% EPS decline, while the $5.1 billion debt load, incomplete GOJO integration and planned CEO departure materially raise execution risk. The FY2027 outlook anticipates substantial sales and EPS growth, but delivery depends on ERP stabilization, margin recovery and successful integration of recent transactions.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Leading brands support competitive moat
- Clorox generated fiscal 2026 net sales of approximately $6.7 billion, and more than 80% of sales came from brands holding No. 1 or No. 2 market-share positions in their categories, supporting a differentiated brand and distribution moat.
- GOJO expands health and hygiene platform
- The April 2026 GOJO acquisition expanded Clorox into Purell and broader health-and-hygiene solutions, adding B2B exposure in healthcare and institutional markets through an established distribution network and installed dispensing base.
- Innovation pipeline remained active
- Clorox continued investing in its product roadmap, launching Clorox PURE, Clorox Screen+ Sanitizing Wipes, Fresh Step Lightweight Litter, Glad ForceFlex MaxStrength LeakGuard bags, new Burt’s Bees products, and additional flavors and scents across key brands.
- Transformation investment reaches milestone
- The company completed its core U.S. ERP implementation in the third quarter of fiscal 2026 after approximately $580 million of incremental transformational investment, with expected longer-term efficiencies across supply chain, digital commerce, innovation and brand building.
- Dividend commitment continued
- The company paid $602 million in dividends during fiscal 2026 and announced a further 1% dividend increase in July 2026, extending its longstanding practice of annual dividend increases.
- FY2027 outlook targets renewed growth
- The FY2027 outlook calls for net sales of $7.59 billion to $7.66 billion, GAAP diluted EPS of $5.41 to $5.71, organic sales growth of 3.5% to 4.5%, and adjusted EPS of $5.70 to $6.00.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Earnings and demand declined
- Fiscal 2026 diluted EPS declined 26% year over year, primarily because of lower net sales and higher manufacturing and logistics costs. The filing also states that macroeconomic uncertainty drove category slowdowns and lower sales.
- Leverage rose after strategic transactions
- Debt increased to approximately $5.1 billion as of June 30, 2026, following the primarily debt-financed $2.15 billion GOJO acquisition and the $476 million cash purchase of P&G’s 20% Glad interest. S&P lowered Clorox’s long-term rating to BBB from BBB+ in February 2026.
- GOJO integration and controls remain incomplete
- GOJO integration is a new execution risk: Clorox had not integrated GOJO’s internal controls into its existing systems as of June 30, 2026 and excluded the acquired business from its internal-control assessment under the one-year acquisition guidance. The transaction may also create channel conflict between B2B and consumer operations.
- CEO succession adds execution uncertainty
- The CEO and Chair announced a planned resignation in May 2026, and the Board began a successor search. The filing warns that the transition could disrupt employees, customers, investors and other stakeholders and complicate execution of the company’s strategy.
- Retailer concentration pressures margins
- Customer concentration remains material: Walmart represented 26% of consolidated net sales in fiscal 2026, while the five largest customers accounted for about half of consolidated net sales. Retailer consolidation and private-label competition could increase pricing pressure and reduce shelf space.
- ERP and cybersecurity exposure persists
- The company completed its ERP replacement in January 2026 but continues to face potential system inefficiencies, data migration issues, security-access gaps and order-fulfillment disruption. The filing also notes that Clorox’s August 2023 cyberattack materially affected business strategy, results and financial condition.
What they said about what is next.
The FY2027 outlook was newly provided rather than compared with a prior FY2027 outlook. Management expects net sales growth of 13% to 14%, organic sales growth of 3.5% to 4.5%, and adjusted EPS of $5.70 to $6.00.
The filing reads worse than the one before it.
What came before.
- 10-Q · April 30, 2026
- Clorox reported Q3 fiscal 2026 results showing revenue of $1.67 billion, flat compared to the prior year and a minor increase in diluted EPS to $1.64 from $1.50. The results reflect ongoing challenges in the operating…
- 10-K · August 8, 2025
- Clorox’s FY2025 10-K presents a company with stable top-line scale ($7.1 billion in net sales) that delivered margin expansion and a 190% increase in diluted EPS year-over-year while continuing its IGNITE transformation…
- 10-Q · October 30, 2024
- Clorox reported quarterly net sales of $1,762 million, up $376 million (+27.1%) versus $1,386 million in the prior-year quarter. Gross profit rose to $807 million (45.8% gross margin) and diluted EPS was $0.80 versus…
- 10-K · August 10, 2023
- Clorox reported fiscal year 2023 net sales of $7.4 billion, up 4% year-over-year, driven by strength in cleaning, bags & wraps, cat litter and water-filtration products and supported by cost-justified pricing and…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing CLX makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever